跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BELBUCA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BELBUCA
Authorized
STANDARD
BELBUCA
purdue pharma
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
62e32c374ff3de85
Company
purdue pharma
Type
Standard
Approval Details
Approval Id
62e32c374ff3de85
Drug Approval Canada Name
BELBUCA
Product Name
BELBUCA
Status
Cancelled Post Market
Status Date
2019-05-31
Original Market Date
2018-01-17
Din
02465256
Drug Class
Human
Dosage Form
Film, Soluble
Route Of Administration
Buccal
Schedule
Narcotic (CDSA I)
Ahfs
28:08.12
Atc Original
N02AE01 BUPRENORPHINE
Atc Name
n 02 ae 01
Aig Number
0142241005
Company Name
purdue pharma
Company Address
310, 3381 Steeles Avenue East, Toronto, Ontario, Canada, M2H 3S7
Active Ingredients
BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)
300 MCG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
62e32c374ff3de85
Type
Standard
Back to Health Canada Approvals